Liquid versus Semi-Solid Culture Medium for Differentiation of Human Mast Cells from Hematopoietic Stem Cells in Bone Marrow


Goksu-Erol A. Y., AKINCI E., UYSAL H., DEMİR DORA D., SALİM O.

Annual Meeting of the Clinical-Immunology-Society (CIS) / Immune Deficiency and Dysregulation North American Conference, Colorado, Amerika Birleşik Devletleri, 2 - 05 Nisan 2020, cilt.40 identifier

  • Yayın Türü: Bildiri / Özet Bildiri
  • Cilt numarası: 40
  • Basıldığı Şehir: Colorado
  • Basıldığı Ülke: Amerika Birleşik Devletleri
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Liquid versus Semi-Solid Culture Medium for Differentiation of

Human Mast Cells from Hematopoietic Stem Cells in Bone Marrow

A. Yasemin Göksu-Erol, MD1, Ersin Akıncı, PhD2, Hilmi Uysal, MD3,

Devrim Demir Dora, PhD4, Ozan Salim, MD5

1Assoc. Prof. Dr., MD/Akdeniz University, Faculty of Medicine,

Histology and Embryology Department

2Assist. Prof./Akdeniz University, Faculty of Agriculture, Department of

Agricultural Biotechnology. Head of Enzyme and Microbial

Biotechnology Division.

3Prof./Akdeniz University, Faculty of Medicine, Department of

Neurology

4Assist. Prof./Akdeniz University, Faculty of Medicine, Department of

Pharmacology

5Akdeniz University, Faculty of Medicine, Department of Internal

Medicine, Division of Hematology

Abstract/Case Report Text

Introduction:Mast cells (MCs) are hematopoietic-derived immune cells,

whose precursors migrate within tissues reaching maturation and differentiation.

Masitinib, a selective tyrosine kinase inhibitor, is efficient in

controlling the survival, differentiation, and degranulation of MCs.

Aim: To optimize mast cell-differentiation from human bone marrow (BM)

hematopoietic stem cells, and to find best cell culture conditions for proliferation,

differentiation, and maintenance of MCs, which is important when

studying particularly MCs’ response to cytotoxic compounds.

Material-Methods: To produce MCs in vitro, the first method (M1) we

used was a modified semi-solid culture method (1). Briefly; human BM

mononuclear cells (MNCs) were obtained with Ficoll gradient from BM

sample of a patient with idiopathic thrombocytopenic purpura. Colonyforming

unit (CFU)-mast was developed from MNCs in methylcellulose

medium supplemented with SCF (200ng/ml) + IL-6 (50ng/ml), and IL-3

(1ng/ml; only first week). 5-6 weeks later mast cell colonies were transferred

into suspension cultures, in which MCs matured and multiplied up

to 7-8 weeks and were used in experiments till 10th week of culture. On

the other hand, in our second method (M2); MNCs were separated by

Ficoll, seeded in 6 well-plates with IMDM containing FBS 2%, Pen/

Strep, and a little amount of methylcellulose, and incubated at 37oC,

5%CO2. Cultures were then supplemented with IMDM (FBS 1%) +

SCF (100ng/ml) + IL-6 (50ng/ml) on day 4; and IMDM (FBS 2%) +

SCF (100ng/ml) + IL-6 (50ng/ml) + IL-3 (1ng/ml) on day 9. Beginning

on day 18 till the end, IMDM (FBS 2%) + SCF (100ng/ml) + IL-6

(50ng/ml) were added to cultures.

For both methods, morphological assessment of colonies/cells were evaluated

under an inverted microscope (Figure 1 and 2). Verification ofMCs

was performed by immunoflorescence staining for anti-tryptase and -

chymase antibodies, and by toluidine blue staining. Macrophages were

verified by anti-CD-68 immunoflorescence staining. MCs were exposed

to masitinib or DMSO for the evaluation of dose-related effects of

masitinib, and cytotoxicity was evaluated by MTT assay.

Results: In M2, culture conditions were easier to handle compared toM1.

In M2, high amounts of MCs in immature and pre-mature forms were

appeared as early as 15-18 days, and peak levels of proliferation rate was

around 2-4 weeks of culture, which was about 3 weeks earlier than M1.

Culture could be maintained till 10 weeks in both methods. Although

MCs are non-adherent cells, in liquid method adherent BM cells such

as fibroblasts, endothelial cells and mesenchymal stem cells have adhered

to the plate and grown up, providing an attachment site for MCs and

serving as a naturalBMnest,mimicking in-vivo environment, forMCs to

grow and proliferate (Figure 2). Attachment of MCs has provided medium

exchange available without changing culture dishes.WhenMCs were

exposed to masitinib (0.5, 1, and 2 μM/μl), approximate survival rates

were 75%, 72%, 69%, respectively.

Discussion: In our liquid medium method, the adherent BM cells not only

provided a natural nest supporting MC development and differentiation,

they also served as an attachment site for MCs. As the cells slightly adhered,

when trypsinized shortly, they easily detached and used for experiments.

And we also report for the first time that adding a little amount of methylcellulose

to the liquid medium provides ease of aggregation of CFUs, and

easy development of MCs. We suggest that our liquid culture may be

superior to semi-solid method, that it is faster and easier to handle.

Ref. 1. Ozdemir O. Evaluation of human mast cell-mediated cytotoxicity

by DIOC18 target cell labeling in flow cytometry. Journal of

Immunological Methods. 319, 98–103; 2007.